This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before making health decisions based on this content.
By SterlingMedicalCenter.org Editorial Team | Last verified: August 2026
In This Article
- What Hypothyroidism Is: Classification and Origins
- How Hypothyroidism Develops: The Mechanism
- What the Research Shows: Diagnosis Evidence and Treatment Outcomes
- Forms and Bioavailability of Thyroid Hormone Replacement
- Who Should Consider Hypothyroidism Treatment and Who Should Avoid
- Safety and Side Effects of Hypothyroidism Treatment
- Key Takeaway: Hypothyroidism Diagnosis and Treatment
What Hypothyroidism Is: Classification and Origins
Hypothyroidism is a condition in which the thyroid gland fails to produce sufficient thyroid hormones—primarily thyroxine (T4) and triiodothyronine (T3)—to meet the body's metabolic needs. This small, butterfly-shaped gland sits at the base of the neck and controls how quickly your body burns calories and uses energy.
The condition is classified into two main types:
Primary Hypothyroidism
The thyroid gland itself is damaged or dysfunctional. The most common cause worldwide is iodine deficiency; in iodine-sufficient regions like North America, autoimmune thyroiditis (Hashimoto's disease) is the leading cause. Other causes include thyroid surgery, radioactive iodine treatment, certain medications (lithium, amiodarone), and radiation therapy.
Secondary Hypothyroidism
The pituitary gland or hypothalamus fails to send adequate signals to the thyroid. This is less common and usually occurs with other pituitary dysfunction.
Hypothyroidism affects approximately 1–2% of the U.S. population, with prevalence increasing with age and female sex. Risk increases significantly after age 60 and is 5–8 times more common in women.
How Hypothyroidism Develops: The Mechanism
The thyroid operates within a feedback loop called the hypothalamic-pituitary-thyroid (HPT) axis. When thyroid hormone levels drop, the pituitary gland releases thyroid-stimulating hormone (TSH) to stimulate the thyroid to produce more T4 and T3. When levels are adequate, the pituitary reduces TSH production.
In hypothyroidism, this system breaks down:
- In primary hypothyroidism: The damaged thyroid cannot respond to TSH signals, so T4 and T3 remain low while TSH rises (the body's attempt to compensate). This is why elevated TSH is a key diagnostic marker.
- In secondary hypothyroidism: The pituitary fails to produce adequate TSH, so both TSH and thyroid hormones are low.
Thyroid hormones regulate metabolic rate, heart rate, body temperature, digestion, and cognitive function. When these hormones decline, metabolism slows, causing fatigue, weight gain, cold intolerance, and cognitive symptoms.
What the Research Shows: Diagnosis Evidence and Treatment Outcomes
Diagnostic Testing for Hypothyroidism
TSH measurement (Evidence Grade A): TSH is the most sensitive screening test. A normal TSH range is typically 0.4–4.0 mIU/L, though this varies slightly by lab and population. Elevated TSH (above 4.0 mIU/L) in the presence of low or low-normal free T4 indicates primary hypothyroidism. Elevated TSH with low TSH indicates secondary hypothyroidism and warrants pituitary evaluation.
Free T4 measurement (Evidence Grade A): Reflects the active, unbound hormone available to tissues. Normal range is approximately 0.8–1.8 ng/dL. Free T4 directly assesses thyroid hormone sufficiency and guides treatment dosing.
Thyroid peroxidase (TPO) antibodies (Evidence Grade A): Present in 90% of Hashimoto's patients, confirming autoimmune etiology. Not required for diagnosis but helps identify cause.
Treatment Efficacy: Hormone Replacement Therapy
Levothyroxine (synthetic T4) is the first-line treatment, supported by extensive evidence (Evidence Grade A). Large randomized controlled trials and decades of clinical experience demonstrate that appropriate dosing normalizes TSH and free T4 levels and relieves symptoms in 90% of patients.
Starting doses: Typically 25–50 mcg daily for most adults; elderly or those with cardiac disease start lower (12.5–25 mcg) due to increased sensitivity.
Dose adjustment: TSH is rechecked 6–8 weeks after initiation or dose change. The goal TSH for most patients is 0.5–2.5 mIU/L, though target ranges vary by age and clinical circumstance.
Long-term outcomes: Studies show that patients on stable levothyroxine doses maintain normal metabolic function, normal heart rate and blood pressure, and resolution of hypothyroid symptoms. Quality-of-life measures improve significantly within 3–6 months of adequate treatment.
Combination T4/T3 therapy: Some patients report better symptom control with added liothyronine (T3); however, randomized controlled trials show no significant benefit over levothyroxine alone for most patients (Evidence Grade B). This remains a consideration for select cases under specialist care.
Forms and Bioavailability of Thyroid Hormone Replacement
Levothyroxine Forms
Tablets: Most common and least expensive. Absorption varies by formulation and patient factors (10–80% bioavailability). Generic and brand versions (Synthroid, Levoxyl) are available.
Liquid formulation: Slightly better absorption in patients with malabsorption disorders.
Absorption factors: Food, especially calcium and iron supplements, reduces levothyroxine absorption by 20–30%. The medication should be taken on an empty stomach, 30–60 minutes before breakfast. Coffee and certain foods can also interfere.
Bioavailability Considerations
Patients switching between generic and brand-name products may experience fluctuations in T4 levels. The FDA allows a 20% variation between generic formulations, which can be clinically meaningful. Consistency in one formulation is preferred; if switching is necessary, TSH should be rechecked after 6–8 weeks.
Who Should Consider Hypothyroidism Treatment and Who Should Avoid
Who Should Be Treated
- TSH > 4.0 mIU/L with low or low-normal free T4
- Symptomatic patients with borderline TSH elevation (4.0–10 mIU/L) and clinical hypothyroid symptoms
- Pregnant women or those planning pregnancy with TSH > 2.5 mIU/L (stricter target)
- Patients with overt hypothyroidism (TSH > 10 mIU/L) regardless of symptoms
Special Considerations
Subclinical hypothyroidism: Elevated TSH (4.0–10 mIU/L) with normal free T4. Treatment is individualized; younger, asymptomatic patients may be monitored; older patients or those with cardiovascular disease or symptoms are more likely to benefit from treatment (Evidence Grade B).
Pregnancy: Untreated hypothyroidism in pregnancy increases risk of miscarriage, preeclampsia, and fetal neurodevelopmental impairment. All pregnant women with hypothyroidism should be treated; TSH targets are stricter (0.5–2.5 mIU/L in first trimester).
Cardiac disease: Levothyroxine increases cardiac workload. Patients with coronary artery disease or arrhythmias require lower starting doses and slower titration to avoid angina or arrhythmia precipitation.
Safety and Side Effects of Hypothyroidism Treatment
Levothyroxine Safety Profile
Levothyroxine is well-tolerated when dosed appropriately. Adverse effects are almost exclusively related to overdosage (iatrogenic hyperthyroidism), which can cause:
- Palpitations and tachycardia
- Tremor and anxiety
- Heat intolerance and sweating
- Bone loss (with chronic over-replacement)
- Atrial fibrillation (particularly in older adults)
Drug Interactions
Calcium supplements: Reduce levothyroxine absorption by 20–30%; separate dosing by 4+ hours.
Iron supplements: Similar reduction in absorption; separate by 4+ hours.
Proton pump inhibitors and H2 blockers: Reduce stomach acid, impairing levothyroxine absorption; may require higher doses.
Estrogen-based hormonal contraceptives: May increase levothyroxine requirement by increasing TBG (thyroxine-binding globulin).
Amiodarone, lithium, interferon-alpha: Can cause hypothyroidism; TSH monitoring is warranted in patients on these medications.
Monitoring Requirements
TSH and free T4 should be checked 6–8 weeks after starting therapy or changing dose, then annually once stable. More frequent monitoring may be needed during pregnancy, with dosing changes, or when new medications are added.
Key Takeaway: Hypothyroidism Diagnosis and Treatment
Hypothyroidism is a common, highly treatable endocrine condition. Diagnosis depends on blood tests (TSH and free T4), not symptoms alone. Levothyroxine replacement is the gold-standard treatment and restores normal metabolism and symptom relief in the vast majority of patients. Success requires appropriate dosing, timing of administration (empty stomach), avoidance of absorption-interfering substances, and regular monitoring to maintain TSH in the goal range. If you have symptoms of hypothyroidism—persistent fatigue, weight gain, cold intolerance, or cognitive slowing—ask your doctor for thyroid testing. With proper diagnosis and treatment, quality of life can be fully restored.
This article is for general information purposes only and does not constitute medical advice. Consult your doctor or qualified healthcare provider before making changes to your health routine.